BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shakhbazau A, Potapnev M. Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation. Cytotherapy 2016;18:1245-55. [DOI: 10.1016/j.jcyt.2016.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Masgrau R, Guaza C, Ransohoff RM, Galea E. Should We Stop Saying 'Glia' and 'Neuroinflammation'? Trends Mol Med 2017;23:486-500. [PMID: 28499701 DOI: 10.1016/j.molmed.2017.04.005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
2 Luo H, Li D, Chen Z, Wang B, Chen S. Manufacturing and banking canine adipose-derived mesenchymal stem cells for veterinary clinical application. BMC Vet Res 2021;17:96. [PMID: 33648493 DOI: 10.1186/s12917-021-02791-3] [Reference Citation Analysis]
3 Duma C, Kopyov O, Kopyov A, Berman M, Lander E, Elam M, Arata M, Weiland D, Cannell R, Caraway C, Berman S, Scord K, Stemler L, Chung K, Khoudari S, McRory R, Duma C, Farmer S, Bravo A, Yassa C, Sanathara A, Singh E, Rapaport B. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol Biol Rep 2019;46:5257-72. [PMID: 31327120 DOI: 10.1007/s11033-019-04983-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
4 Salari V, Mengoni F, Del Gallo F, Bertini G, Fabene PF. The Anti-Inflammatory Properties of Mesenchymal Stem Cells in Epilepsy: Possible Treatments and Future Perspectives. Int J Mol Sci 2020;21:E9683. [PMID: 33353235 DOI: 10.3390/ijms21249683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Hlebokazov F, Dakukina T, Potapnev M, Kosmacheva S, Moroz L, Misiuk N, Golubeva T, Slobina E, Krasko O, Shakhbazau A, Hlavinski I, Goncharova N. Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients. Clin Neurol Neurosurg 2021;207:106736. [PMID: 34119901 DOI: 10.1016/j.clineuro.2021.106736] [Reference Citation Analysis]
6 Thakor DK, Wang L, Benedict D, Kabatas S, Zafonte RD, Teng YD. Establishing an Organotypic System for Investigating Multimodal Neural Repair Effects of Human Mesenchymal Stromal Stem Cells. Curr Protoc Stem Cell Biol 2018;47:e58. [PMID: 30021049 DOI: 10.1002/cpsc.58] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]